Blood Sugar Level Archives - InnoHEALTH magazine

Digital Diabetes Management Market

InnoHEALTH Magazine — Fri, 21 Jun 2019 11:14:48 +0000

Diabetes is one of the worst nightmares that is spreading like a wildfire in all the regions of the world. According to the International Diabetes Federation, almost one in every ten people suffer from diabetes and the number is expected to increase further,if proper measures are not taken. The hectic lifestyles and changing food habits of people across the globe make them more vulnerable to this epidemic. For a long period of time, oral drugs, blood glucose monitoring devices, insulin pumps, and others are supporting diabetic people to control their blood sugar levels. However, the advent of new technologies has taken this to an all new level.

The rapid adoption of technology in healthcare also touched the area of diabetes care management; digitizing the available methods to provide more comfort and simplicity to the affected people. The sudden wave of smartphones had a great impact on the digital diabetes care as it brings forth several smart apps that help the consumers to track their blood glucose levels, diet and physical activities, sleep pattern, and so on at their fingertips. More innovations are being carried out to provide more compact and efficient solutions to diabetic people, especially the geriatric population in remote areas of the world.

The Global Digital Diabetes Management Market is is expected to cross around USD 20 billion by the end of 2024, registering a CAGR value of 24% during 2019 to 2025; as per the research report published by Research Cosmos.The growing adoption of technology and increasing acceptance of smart applications by consumers along with the extensive spread of diabetes in all the demographics, people are expected to drive the demand for digital diabetic solutions. The major benefit of these solutions is that they can be availed within the comfort of home, without any hospital visits or medical professional support. The portability offered by these digital solutions allows the patients to carry them anywhere without any hassle.

One of the most noteworthy trends in digital diabetes management is the introduction of wearable devices. These devices can be worn on the body with much ease and are capable to provide round the clock assistance to the consumer, along with the maintenance of style quotient. The advantage of these wearable could be continuous monitoring of the blood glucose levels of the person, providing required amounts of insulin to body without any external assistance, sharing patient condition to respective healthcare provider or doctor, providing regular alerts about health status, offering suggestions to improve health and so on and so forth.

The increasing acceptance for digital diabetes management has pushed many manufacturers in healthcare to concentrate more on the development of innovative solutions to grab the major chunk of the world profits. Several acquisitions, mergers, collaborations and new product launches have become the important strategy of many leading players to improve their market holdings. One such popular event in the recent years is the partnership of digital diabetes platform provider GlucoMe with the leading German pharmaceutical company Merck KGaA to offer the digital diabetes platform services to various hospitals in Vietnam, which has one of the fastest growing diabetic cases in the Asia-Pacific.

The major challenge these digital solutions face is to reach the rural population in many developing regions of the world. The lack of awareness about the availability of these features due to the improper publicity and initiatives from the government can be a stronghold for this market. Additionally, the high costs of smart devices and unstructured regularization of the products, which can lead to the availability of counterfeit products that are harmful to the body could act as limiting factors for the rapid adoption of the digital diabetes solutions among the global population.

However, the future looks more promising for the digital care in diabetes with the augmenting innovations in the technology such as data analytics and artificial intelligence (AI). These technologies will further intensify the services offered currently at more affordable prices. In particular, AI will play a prominent role in the increasing efficiency and care of these solutions. Similarly, the added style factor in wearable devices by several manufactures around the world will further create huge demand for digital diabetic solutions. Furthermore, the growing elderly population of the world, who prefer home healthcare will become the lucrative segment of end-users for these devices; pulling the market players to focus more on this section.

Globally, North America has been the demanding region with the significant market share in digital diabetes management market. The contribution from the developed nations of this region like the USA, Canada and Mexico has been tremendous in the recent years. The increasing cases of diabetes, rapid adoption of advanced technologies in medical care, sophisticated healthcare infrastructure, mounting number of geriatric populations, awareness about the benefits of these devices among the population and the favourable government reimbursements have been the driving factors for the growing demand of digital diabetes management in the North American nations.

Some of the prominent names in the global digital diabetes management market are Abbott Laboratories, Merck KGaA, Roche Diagnostics, AgaMatrix, Glooko Inc, Tandem Diabetes Care, Medtronic, Dexcom, Lifescan, DarioHealth, Tidepool, Insulet Corporation, B. Braun, Ascensia Diabetes Care, and others. All these players are investing in their R&D activities to implement and introduce more innovative solutions in the world digital diabetes management market.

About the author:

Kevin Stewart is currently working with Research Cosmos as Market Research Manager; a firm that does Global Market Intelligence.

The post Digital Diabetes Management Market appeared first on InnoHEALTH magazine.

Menace of Non-Communicable diseases: A far reaching impact

InnoHEALTH Magazine — Wed, 28 Mar 2018 08:49:26 +0000

Non-communicable diseases (NCDs) represent a major peril to the economic growth and development and human health of any nation. The economic loss to India is pegged at $4.58 trillion before 2030 due to NCDs and mental health. The vicious cycle of high out-of-pocket expenditure on health, poor economic growth, workforce productivity loss and rising disease burden are intricately linked to the rising menace of NCDs.

The South Asian region─with a population of more than 1.7 billion─is experiencing a marked demographic transition─characterised by declining birth and death rates and an increasingly aging population. This increase in longevity has also been accompanied by a rise in the prevalence of NCDslike diabetes (78 million cases in 2015). India has the second highest number of diabetic patients in the world, at about 69 million, after China, and this figure is likely to reach 140 million by 2040 and almost half of them remain un-diagnosed. A recent study showed that seven out of ten diabetics in India – especially those in the 20-24 age group – do not take enough steps to control their blood sugar level – even after diagnosis.

The Economic Impact of Diabetes, As per a study conducted by the Indian Institute of Public Health, the number of diabetes patients in the country is likely to go up to 120 million in next 20 years as against the current 70 million. On an average a diabetic patient spends about INR 25,000 annually to manage the disease and its associated complications. Beyond placing a financial strain on the patient due to treatment expenditures, poor management of diabetes significantly impacts the patients’ quality of life: it may lead to loss of productivity due to multiple hospital visits, elevating rates of absenteeism, diminishing the energy and focus of a productive workforce, and depleting critical workplace skills ultimately leading to reduced mobility and span of life. Diabetes related complications like kidney failure, nerve damage along with obesity, dyslipidemia and hypertension make diabetes management quite complex for clinicians.

In this context, it becomes important that healthcare professionals have access to more educational resources to remain updated about how to tackle the diabetes epidemic. But due to scarcity of time and high patient load in South Asian healthcare facilities, medical practitioners find it very difficult to update their knowledge. Remaining updated can help clinicians offer better diabetes management options to their patients.

A Possible Solution: E-Learning Courses e-Learning programs can help clinicians in acquiring skills required to address the growing complex management of diseases. E-learning courses can be tailored to fit the clinicians schedule, delivering content right at the moment when it is demanded by the doctor. Interactive e-learning programs also offer peer to peer learning, thus enabling clinicians to discuss learning from key cases. Those e-learning programs which also offer the opportunity of contact classes, offer a richer and immersive learning experience.

An effective e-learning program will incorporate guidelines for determining the correct and appropriate blend of instructional strategies, including on-line learning, face-to-face instruction, and skill demonstrations, thus facilitating the learning of a clinician far beyond than traditional learning materials. Unlike traditional CMEs, e-learning can be designed to be self-paced, and research has indicated that e-learning reduces the learning time by at least 25-60% when compared to traditional learning, which can be an added advantage for time-constrained clinicians.

Intelligent e-learning management systems also adapt and learn from the learners’ aptitude and change and deliver a personalized learning experience. The right mix of video, audio, and text content formats help to ensure that delivery of content is mapped to the medium most appropriate & relevant to concept development.

Keeping in mind these perspectives, a Six Months Certification Course in Diabetes in partnership with Fortis C-DOC Hospital was launched by BMJ in South Asia. This course is endorsed by the Royal College of Physicians. This is a six months online learning course offered in two formats: with hands-on training and online-only – to cater to the learning needs of clinicians in South Asia.

Courses such as these will go a long way in knowledge & skill upgradation for clinicians in areas which the country faces a high disease burden. Such courses are clinician-centric and learner-led, and have been developed keeping in mind the real and on-ground challenges faced by doctors in South Asia.

Want to write for InnoHEALTH? send us your article at magazine@innovatiocuris.com

Read all the issues of InnoHEALTH magazine:
InnoHEALTH Volume 1 Issue 1 (July to September 2016) – https://goo.gl/iWAwN2
InnoHEALTH Volume 1 Issue 2 (October to December 2016) – https://goo.gl/4GGMJz
InnoHEALTH Volume 2 Issue 2 (April to June 2017) – https://goo.gl/Nv3eev
InnoHEALTH Volume 2 Issue 4 (October to December 2017) – http://amzn.to/2B2UMLw
InnoHEALTH Volume 3 Issue 1 (January to March 2018) – https://goo.gl/fksdQx

Connect with InnovatioCuris on:
Facebook: https://www.facebook.com/innovatiocuris
Twitter: https://twitter.com/innovatiocuris
LinkedIn: https://www.linkedin.com/groups/7043791
Stay updated about IC, visit: www.innovatiocuris.com

The post Menace of Non-Communicable diseases: A far reaching impact appeared first on InnoHEALTH magazine.